PE firms investing in life science

Is anyone on this forum close to the growing life science investing world that seems to be coming out of traditional PE? Seems that Bain Capital started a fund that bridges the gap between biotech VC and the public markets, and BX soon followed suit with an acquisition of Clarus. Would love to get the perspective of anyone currently in this space as to what these entrances have done and where they see things going in the next few years in the life sciences